NasdaqCM:SNDLPharmaceuticals
SNDL (NasdaqCM:SNDL) Stock Struggles To Shake Losses Despite C$235.8m Revenue
SNDL slipped about 2% in midday trading, which hardly looks like panic when you set it against what just came out of the quarter. The headline is simple. Revenue held at a substantial C$235.8m while the company stayed in the red, with a net loss of C$7.8m and free cash flow still negative.
For a stock that has already fallen over the past month, today’s muted move suggests investors are wrestling less with surprise and more with fatigue. The key question now is whether this latest loss...